Invention Grant
- Patent Title: 3,5-diaminopyrazole kinase inhibitors
-
Application No.: US14552226Application Date: 2014-11-24
-
Publication No.: US09382237B2Publication Date: 2016-07-05
- Inventor: Erik Dean Raaum , Garrett Thomas Potter , Tai Wei Ly
- Applicant: AXIKIN PHARMACEUTICALS, INC.
- Applicant Address: US CA San Diego
- Assignee: Axikin Pharmaceuticals, Inc.
- Current Assignee: Axikin Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/497 ; A61K31/506 ; A61K31/4523 ; A61K31/4427 ; A61K31/4155 ; C07D413/12 ; C07D403/12 ; C07D231/38 ; C07D401/12 ; C07D405/12 ; C07D409/14 ; C07D417/12 ; A61K31/415 ; A61K31/4178 ; A61K31/4184 ; A61K31/427 ; A61K31/4439 ; A61K31/454 ; A61K31/496 ; A61K31/69 ; A61K45/06 ; C07D409/12 ; C07F5/02 ; C07D401/14 ; A61K31/416 ; A61K31/4545
Abstract:
Provided herein are 3,5-diaminopyrazoles, for example, compounds of Formula IA, that are useful for modulating regulated-in-COPD kinase activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a RC kinase-mediated disorder, disease, or condition.
Public/Granted literature
- US20150080398A1 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS Public/Granted day:2015-03-19
Information query
IPC分类:
